Enrolling by invitation

eAMS-PharmElectronic Asthma Management System for Pharmacies

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This clinical trial is an interventional study aimed at improving asthma management in pharmacies through an electronic system. It will assess the proportion and trend of medication adjustments, asthma control assessment, and action plan creation for patients.

What is being tested

Pharmacy Clinical Decision Support System for Asthma Management

Behavioral
Who is being recruted

Asthma+6

+ Bronchial Diseases

+ Hypersensitivity

Over 16 Years
See all eligibility criteria
How is the trial designed

Services Research Study

Interventional
Study Start: June 2025
See protocol details

Summary

Principal SponsorUnity Health Toronto
Last updated: December 11, 2025
Sourced from a government-validated database.Claim as a partner

Study start date: June 23, 2025

Actual date on which the first participant was enrolled.

Asthma is a common long-term condition that affects many adults, and controlling it can be challenging. Despite available treatments, many people in Canada struggle with poorly controlled asthma due to several gaps in care, such as not following guidelines, not adjusting medications when needed, and not getting proper action plans or specialist referrals. This study focuses on a tool called the Electronic Asthma Management System (eAMS), which has been successful in primary care settings and aims to improve asthma management by involving pharmacists. Pharmacists are increasingly important in healthcare, and this study seeks to use the eAMS to help them provide better asthma care, potentially making it easier for patients to manage their condition and easing the load on primary care doctors. In the study, participants will use the eAMS tool, which is a web-based system that collects information about their asthma and provides tailored advice. Using a questionnaire, patients will enter details about their asthma symptoms, which the system then analyzes to offer guidance on managing their condition. The tool can recommend changes to medication and create a personalized asthma action plan. Pharmacists will use this information to support asthma patients more effectively, helping to ensure they have the right care and medications. While the study doesn't list specific risks or benefits, it aims to improve asthma control and make healthcare more efficient by involving pharmacists in chronic disease management.

Official TitleThe Electronic Asthma Management System in Pharmacies (eAMS-Pharm) 
Principal SponsorUnity Health Toronto
Last updated: December 11, 2025
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

100 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Services Research Study

These studies look at how healthcare is delivered, managed, and organized. They aim to improve care quality, patient experience, and access to treatment.


Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 16 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

AsthmaBronchial DiseasesHypersensitivityHypersensitivity, ImmediateImmune System DiseasesLung DiseasesLung Diseases, ObstructiveRespiratory HypersensitivityRespiratory Tract Diseases

Criteria

* Eligible patients would be those who have asthma and are seen at one of the three study pharmacies during the study period * Eligible pharmacy team members would be staff (pharmacists/RPhTs/assistants/students) at any one of the three study pharmacies

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Active Comparator
Throughout the intervention period, the eAMS-Pharm will be provided to pharmacists/RPhTs/assistants/students (for use in eligible patients).

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 3 locations

Suspended

Medical Place Pharmacy

Ajax, CanadaSee the location
Suspended

LiveWell Pharmacy

Niagara Falls, Canada
Suspended

Westmount Place Pharmacy

Waterloo, Canada
Enrolling by invitation3 Study Centers